Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
-1.96%
-$2.45
$122.63
16:39 26/05/15

   Spread betting | CFDs | Stockbroking   Trade now with IG Sponsored by IG. Losses can exceed deposits

$122.63
16:39 26/05/15
DAILY VARIATION
-1.96%
-$2.45
VOLUME
1,139,422
DATA
52 Week High
$135.82
52 Week Low
$64.63
Shares Issued
243.75m
Market Cap
$30,488.50m
RiskGrade
n/a
Beta
n/a
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -119.3% -43.8%
ROCE 0.0%
Latest F'cast
P/E -39.1 0.0
PEG 0.0 -999,999.0
Pr/Revenue 51.5 30.4
Pr/Book 27.3
Latest F'cast
Revenue -52.1% -30.0%
PBT 0.0% n/a
EPS 0.0% -463.7%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2010-12-31 143.37 -754.63 -377.00¢ -9.3 0.0 n/a n/a 0.0%
2011-12-31 1,410.63 60.44 14.00¢ 237.2 0.0 n/a n/a 0.0%
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 -314.00¢ -37.8 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2015-12-31 983.75 -430.50 -182.46c 0.0 n/a 0% 0.00c 0.0%
2016-12-31 2,726.20 1,106.23 365.83c 3,513.5 n/a 0% 0.00c 0.0%

Regulatory News

No results found

Latest Sharecast News

No results found

Newspaper Links

No results found